Regional Health Authorities

Baird R.M. (1985) Microbial contamination of non-sterile pharmaceutical products made in hospitals in the North East Regional Health Authority. J Clin Hasp Pharm, 10, 95-100. 

In 1993 the four Regional Health Authorities (RHAs) that existed at that time established PHARMAC as a non-profit making Crown Agency. PHARMAC is now a wholly owned subsidiary of the Health Funding Agency. 

Cost-per-case contracts are normally channelled by third-party purchasers, such as district or regional health authorities. In a variant of this mechanism, the cost-per-volume contract, a minimum volume of service is purchased, with the cost changing as the volume increases. 

While enforcement authority for informed consents exists in the FDA and in other non-US national and regional health authorities, the enforcement agency responsible for HIPAA in the US is the Office of Civil Rights (OCR) within the Department of Health and Human Services (HHS). Monitoring of HIPAA will likely occur by the Office of the Inspector General. 

The following list provides typical clinical support applications that can be integrated with the health informatics solution for decision support and outcome analysis. The applications that exist throughout the regional health authority jurisdictions can be categorized as follows ... 

Things will sometimes go wrong. The following illustrates another hypothetical scenario of a more complex case. It describes the activities and events from different perspectives, such as from the perspective of patient, physician, acute care unit manager and regional health authority. It then briefly describes the events occurred behind scenes. The hypothetical scenario starts with a citizen experiencing some mild chest pain while at home, tries simple remedies (e.g., antacid, Tylenol), but pain persists. This scenario starts with the patient perspective. 

Policy makers (e.g., hospital administrators, regional health authorities, guideline developers, and quality-assurance staff) communicate with practitioners about practice patterns, new guidelines, and the like, and with patients about uses of services. 

The research was funded by the Western Norway Regional Health Authority C WRHA). 

Report of the inquiry into the London Ambulance Service, South West Thames Regional Health Authority, Febmary 1993, para 3046. 

For its part, COLIPA, in collaboration with the Institute for Reference Materials and Measurements (IRMM), the Rome Istituto Superiore di Sanith (ISS), the Tuscany Regional Health Authorities (ARPAT) and the University of Siena (Italy), has published a compilation of analytical methods aimed specifically at cosmetic products (Anselmi et al., 2004). These methods are intended to identify and quantitatively determine the substances listed in the various annexes of the EU Cosmetics Directive. Although most of these methods are not official , they do, at least, exist. 

---